- Home
- VOR vs TLRY Comparison
VOR vs TLRY Comparison
Compare VOR & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | TLRY |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.3M | 688.9M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VOR | TLRY |
|---|---|---|
| Price | $14.43 | $4.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $45.33 | ★ $72.33 |
| AVG Volume (30 Days) | 742.5K | ★ 3.2M |
| Earning Date | 05-11-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.36 |
| 52 Week High | $49.95 | $15.70 |
Technical Indicators
Market Signals| Indicator | VOR | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 38.19 |
| Support Level | $13.73 | $4.97 |
| Resistance Level | $14.73 | $5.71 |
| Average True Range (ATR) | 0.95 | 0.27 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 59.80 | 18.13 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.